Ovarian tumors that present in the reproductive age group are mostly benign while about 30% in the postmenopausal age group are malignant. 1 They present themselves in various clinical forms and surprisingly many a time as vague, non-gynaecological complaints Influence of menarche, menopause, nulliparity, mean age of presentation and type of tumour needs to be identified. This will help develop a analysis for clinicopathological features of ovarian tumour.
Material and Methods: This was a prospective observational study at a tertiary care hospital which included 112 patients satisfying the inclusion criteria. Incidence of ovarian tumour and clinicopathological features of ovarian tumours was studied.
Statistical analysis: Percentage distribution of clinical and pathological features of ovarian tumours was studied.
Result: The incidence of ovarian tumours from 1 January 2017 to 31 December 2018 was found to be 8.9% of all gynaecological admissions. 14 patients had malignant lesions on HPR. The commonest benign lesion was serous cystadenoma, the commonest malignant lesion being papillary adenocarcinoma.
Conclusion: Thus, it is concluded that on morphological grounds, tumours originating from surface epithelium are the commonest variant and various modalities will help in early detection of malignant lesions of ovary thereby, reducing the mortality rates. Differentiation of a benign tumor from a malignant one is important for determining management and prognosis; hence further similar studies are warranted.